Intervention

Bosutinib

ClinicalTrials.gov intervention label

Clinical trials9
Recruiting0
Common conditions25
Lead sponsors shown5

Clinical trials

9 shown
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid TumorsNCT03023319 · 2019-12-10
COMPLETED
WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 InhibitorNCT03854903 · 2019-04-01
COMPLETED
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs TherapyNCT02638467 · 2015-11-01
COMPLETED
Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase InhibitorsNCT02228382 · 2014-11-07
TERMINATED
A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaNCT02130557 · 2014-07-15
COMPLETED
Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast CancerNCT00959946 · 2009-09-01
TERMINATED
Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast CancerNCT00880009 · 2009-07-30
TERMINATED
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast CancerNCT00793546 · 2009-02-01
TERMINATED
Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy SubjectsNCT00759837 · 2008-10-01
COMPLETED

Common conditions

Breast Cancer2Advanced Breast Cancer1Advanced Breast Cancer (Parts 1 and 2)1Advanced Cholangiocarcinoma (Part 1)1Advanced Colorectal Cancer (Part 1)1Advanced Glioblastoma Multiforme (Part 1)1Advanced Pancreatic Cancer (Part 1)1BCR-ABL Positive1Bladder Cancer1Carcinoma, Non-Small-Cell Lung1Chronic1Hormone Receptor Positive Breast Cancer1Human Epidermal Growth Factor 2 Negative Carcinoma of Breast1Leukemia1Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive1Leukemia, Myeloid, Chronic1Mesothelioma1Metastatic Breast Cancer1Myelogenous1Ovarian Cancer1Peritoneal Cancer1Previously Treated PH + CML1Thymoma1Thymus Cancer1Uterine Cervical Cancer1

Trial status mix

COMPLETED5
TERMINATED4

Phase mix

PHASE14
PHASE24
PHASE31
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.